RAMPs and CGRP receptors

Advances in Experimental Medicine and Biology

Volumn 744, Issue , 2012, Pages 13-24

  Barwell, James ^a   Wootten, Denise ^a   Simms, John ^b   Hay, Debbie L ^c   Poyner, David R ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CHAPERONE; OLCEGEPANT; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOACCUMULATION; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL SURFACE; COMPLEX FORMATION; DRUG RECEPTOR BINDING; DRUG TARGETING; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; RECEPTOR ACTIVITY-MODIFYING PROTEINS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE;

EID: 84859802761     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-2364-5_2     Document Type: Article

References (51)

1. Fluhmann B, Muff R, Hunziker W et al. A human orphan calcitonin receptor-like structure. Biochem Biophys Res Commun 1995; 206(1):341-347.
2. Njuki F, Nicholl CG, Howard A et al. A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin Sci (Lond) 1993; 85(4):385-388. (Pubitemid 23308448)
3. Chang CP, Pearse RV, 2nd, O'Connell S et al. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 1993; 11(6):1187-1195.
4. Poyner DR, Sexton PM, Marshall I et al. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin and calcitonin receptors. Pharmacol Rev 2002; 54(2):233-246. (Pubitemid 34575714)
5. Aiyar N, Rand K, Elshourbagy NA et al. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 1996; 271(19):11325-11329. (Pubitemid 26155969)
6. McLatchie LM, Fraser NJ, Main MJ et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393(6683):333-339. (Pubitemid 28269699)
7. Buhlmann N, Leuthauser K, Muff R et al. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology. 1999; 140(6):2883-2890. (Pubitemid 32245170)
8. Christopoulos G, Perry KJ, Morfis M et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 1999; 56(1):235-242. (Pubitemid 29309833)
9. Hay DL, Poyner DR, Quirion R. International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor. Pharmacol Rev 2008; 60(2):143-145.
10. Hoare SR. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today 2005; 10(6):417-427. (Pubitemid 40450272)
11. Grace CR, Perrin MH, Gulyas J et al. Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand. Proc Natl Acad Sci USA 2007; 104(12):4858-4863. (Pubitemid 47186141)
12. Parthier C, Kleinschmidt M, Neumann P et al. Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci USA 2007; 104(35):13942-13947. (Pubitemid 350003317)
13. Sun C, Song D, Davis-Taber RA et al. Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS. Proc Natl Acad Sci USA 2007; 104(19):7875-7880. (Pubitemid 47185844)
14. Grace CR, Perrin MH, DiGruccio MR et al. NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. Proc Natl Acad Sci USA 2004; 101(35):12836-12841. (Pubitemid 39167545)
15. Hilairet S, Foord SM, Marshall FH et al. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins. J Biol Chem 2001; 276(31):29575-29581.
16. Kuwasako K, Shimekake Y, Masuda M et al. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J Biol Chem 2000; 275(38):29602-29609. (Pubitemid 32043838)
17. Hilairet S, Belanger C, Bertrand J et al. Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1) and beta-arrestin. J Biol Chem 2001; 276(45):42182-42190.
18. Muff R, Leuthauser K, Buhlmann N et al. Receptor activity modifying proteins regulate the activity of a calcitonin gene-related peptide receptor in rabbit aortic endothelial cells. FEBS Lett 1998; 441(3):366-368. (Pubitemid 29065316)
19. Koller D, Ittner LM, Muff R et al. Selective inactivation of adrenomedullin over calcitonin gene-related peptide receptor function by the deletion of amino acids 14-20 of the mouse calcitonin-like receptor. J Biol Chem 2004; 279(19):20387-20391. (Pubitemid 38623485)
20. Heroux M, Breton B, Hogue M et al. Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET. Biochemistry 2007; 46(23):7022-7033. (Pubitemid 46906431)
21. Fraser NJ, Wise A, Brown J et al. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Mol Pharmacol 1999; 55(6):1054-1059. (Pubitemid 29252372)
22. Kuwasako K, Kitamura K, Nagoshi Y et al. Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity. J Biol Chem 2003; 278(25):22623-22630. (Pubitemid 36830320)
23. Kusano S, Kukimoto-Niino M, Akasaka R et al. Crystal Structure of the Human Receptor Activity-Modifying Protein 1 Extracellular Domain. Protein Sci 2008; 17(11):1907-1914.
24. Simms J, Hay DL, Bailey RJ et al. Structure-function analysis of RAMP1 by alanine mutagenesis. Biochemistry 2009; 48(1):198-205.
25. Mallee JJ, Salvatore CA, LeBourdelles B et al. Receptor activity-modifying protein 1 determines the species selectivity of nonpeptide CGRP receptor antagonists. J Biol Chem 2002; 277(16):14294-14298. (Pubitemid 34968045)
26. Qi T, Christopoulos G, Bailey RJ et al. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin and amylin receptor function. Mol Pharmacol 2008; 74(4):1059-1071.
27. Ittner LM, Koller D, Muff R et al. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1. Biochemistry 2005; 44(15):5749-5754. (Pubitemid 40525111)
28. Doods H, Hallermayer G, Wu D et al. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 2000; 129(3):420-423. (Pubitemid 30083862)
29. Hay DL, Christopoulos G, Christopoulos A et al. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl] carbonyl]pentyl]amino]-1- [(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4- (1,4-dihydro-2-oxo-3(2 H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors-the role of receptor activity modifying protein 1. Mol Pharmacol 2006; 70(6):1984-1991. (Pubitemid 44771914)
30. Salvatore CA, Mallee JJ, Bell IM et al. Identification and Pharmacological Characterization of Domains Involved in Binding of CGRP Receptor Antagonists to the Calcitonin-like Receptor. Biochemistry 2006; 45(6):1881-1887. (Pubitemid 43222131)
31. Steiner S, Muff R, Gujer R et al. The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor. Biochemistry 2002; 41(38):11398-11404.
32. Flahaut M, Rossier BC, Firsov D. Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR/RAMP heterodimeric receptors. J Biol Chem 2002; 277(17):14731-14737. (Pubitemid 34952544)
33. Conner AC, Hay DL, Simms J et al. A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: Implications for family B G-protein-coupled receptors. Mol Pharmacol 2005; 67(1):20-31. (Pubitemid 40069963)
34. Aldecoa A, Gujer R, Fischer JA et al. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells. FEBS Lett 2000; 471(2-3):156-160. (Pubitemid 30190056)
35. Udawela M, Christopoulos G, Morfis M et al. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors. Regul Pept 2008; 145(1-3):65-71. (Pubitemid 350296350)
36. Udawela M, Christopoulos G, Tilakaratne N et al. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors. Mol Pharmacol 2006; 69(6):1984-1989. (Pubitemid 43894317)
37. U dawela M, Christopoulos G, Morfis M et al. A critical role for the short intracellular C terminus in receptor activity-modifying protein function. Mol Pharmacol 2006; 70(5):1750-1760.
38. Kuwasako K, Cao YN, Chu CP et al. Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of CGRP and adrenomedullin receptors. J Biol Chem 2006; 281(11):7205-7213. (Pubitemid 43847487)
39. Prado MA, Evans-Bain B, Dickerson IM. Receptor component protein (RCP): A member of a multi-protein complex required for G-protein-coupled signal transduction. Biochem Soc Trans 2002; 30(4):460-464. (Pubitemid 35001577)
40. Cottrell GS, Padilla B, Pikios S et al. Post-endocytic sorting of calcitonin receptor-like receptor and receptor activity-modifying protein 1. J Biol Chem 2007; 282(16):12260-12271. (Pubitemid 47100722)
41. Bomberger JM, Parameswaran N, Hall CS et al. Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking. J Biol Chem 2005; 280(10):9297-9307. (Pubitemid 40409622)
42. Tsujikawa K, Yayama K, Hayashi T et al. Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci USA 2007; 104(42):16702-16707. (Pubitemid 350211080)
43. Zhang Z, Winborn CS, Marquez de Prado B et al. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 2007; 27(10):2693-2703. (Pubitemid 46393588)
44. Marquez-Rodas I, Longo F, Aras-Lopez R et al. Aldosterone increases RAMP1 expression in mesenteric arteries from spontaneously hypertensive rats. Regul Pept 2006; 134(1):61-66.
45. Marquez-Rodas I, Xavier FE, Arroyo-Villa I et al. Increased expression in calcitonin-like receptor induced by aldosterone in cerebral arteries from spontaneously hypertensive rats does not correlate with functional role of CGRP receptor. Regul Pept 2008; 146(1-3):125-130.
46. Dong YL, Green KE, Vegiragu S et al. Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of fetoplacental vessels in preeclamptic pregnancies. J Clin Endocrinol Metab 2005; 90(4):2336-2343. (Pubitemid 40586282)
47. Cueille C, Pidoux E, de Vernejoul MC et al. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure. Biochem Biophys Res Commun 2002; 294(2):340-346. (Pubitemid 34694100)
48. ter Haar E, Koth CM, Abdul-Manan N et al. Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 2010; 18:1083-1093.
49. Barwell J, Gingell JJ, Watkins HA et al. Calcitonin and calcitonin receptor-like receptors: Common themes with family B GPCRs? Br J Pharmacol 2011; in press.
50. Archbold JK, Flanagan JU, Watkins HA et al. Structural insights into RAMP modification of secretin family G protein-coupled receptors: Implications for drug development. Trends Pharmacol Sci. 2011; in press
51. Sexton, PM, Poyner DR, Simms J et al. RAMPS as drug targets. In: Spielmann W, Parameswaran N, eds. RAMPs. Austin/New York: Landes Bioscience/ Springer Science + Business Media, 2012: 63-76.